Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Top Cited Papers
Open Access
- 1 February 2002
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (2) , 267-274
- https://doi.org/10.1128/aac.46.2.267-274.2002
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samplesMolecular Diagnosis, 1999
- Dormancy ofMycobacterium tuberculosis and latency of diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Selection of a gyrA Mutant of Mycobacterium tuberculosis Resistant to Fluoroquinolones during Treatment with OfloxacinThe Journal of Infectious Diseases, 1994
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsNew England Journal of Medicine, 1994
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- Drug resistance in tuberculosis controlTubercle, 1987
- Some comparative aspects of rifampicin and isoniazidTubercle, 1968
- ETHAMBUTOL: A SUBSTITUTE FOR PARA‐AMINOSALICYLIC ACID IN REGIMENS FOR PULMONARY TUBERCULOSISAnnals of the New York Academy of Sciences, 1966
- The Segregation of Streptomycin-Resistant Variants of Mycobacterium tuberculosis into Groups with Characteristic Levels of ResistanceJournal of General Microbiology, 1951